Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Santacana Juncosa E, Rodríguez-Alonso L, Padullés Zamora A, Guardiola J, Rodríguez-Moranta F, Serra Nilsson K, Bas Minguet J, Morandeira Rego F, Colom Codina H, Padullés Zamora N.
Santacana Juncosa E, et al. Among authors: padulles zamora a.
Br J Clin Pharmacol. 2021 Feb;87(2):494-505. doi: 10.1111/bcp.14410. Epub 2020 Jun 26.
Br J Clin Pharmacol. 2021.
PMID: 32495380
Free article.